Cancer Immunosurveillance /
Saved in:
| Imprint: | New York, N.Y. : Humana Press : Springer, [2018]. c2019 |
|---|---|
| Description: | 1 online resource (xiii, 363 pages) : illustrations (some color). |
| Language: | English |
| Series: | Methods in molecular biology, 1940-6029 ; 1884 Springer protocols Methods in molecular biology (Clifton, N.J.) ; v. 1884. Springer protocols (Series) |
| Subject: | |
| Format: | E-Resource Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/11737671 |
Table of Contents:
- Usage of droplet digital PCR (ddPCR) assays for T cell quantification in cancer / Willem H. Zoutman, Rogier J. Nell, and Pieter A. van der Velden
- Economical, quantitative, and robust protocol for high-throughput T cell receptor sequencing from tumor or blood / Imran Uddin, Kroopa Joshi, Theres Oakes, James M. Heather, Charles Swanton, on behalf of the TRACERx consortium, and Benny Chain
- Generation of tumor antigen-specific cytotoxic T lymphocytes from pluripotent stem cells / Xiaoniao Chen, Fengyang Lei, Liqiang Wang, Xiaofang Xiong, and Jianxun Song
- Expansion and adoptive transfer of human V?2+ T cells to assess antitumor effects in vivo / Akshat Sharma, Nicholas A. Zumwalde, and Jenny E. Gumperz
- Usage of single-cell RNA sequencing to unveil immune lymphoid cell precursors / Yong Yu and Pengtao Liu
- Isolation, expansion, and characterization of natural killer cells and their precursors as a tool to study cancer immunosurveillance / Monica Parodi, Raffaella Meazza, Chiara Vitale, Gabriella Pietra, Paolo Carrega, and Massimo Vitale
- CD107a degranulation assay to evaluate immune cell antitumor activity / Seila Lorenzo-Herrero, Christian Sordo-Bahamonde, Segundo Gonzalez, and Alejandro López-Soto
- Flow cytometric NK cell-mediated cytotoxicity assay to evaluate anticancer immune responses in vitro / Seila Lorenzo-Herrero, Christian Sordo-Bahamonde, Segundo González, and Alejandro López-Soto
- Mouse models to study natural killer cell-mediated immunosurveillance and metastatic latency / Vidhya R. Nair and Srinivas Malladi
- Tumor-associated macrophage isolation and in vivo analysis of their tumor-promoting activity / Nicholas M. Clark and Paula D. Bos
- Conditional genetic ablation mouse models as a tool to study cancer immunosurveillance in vivo / Magali Dupont and Christian A. J. Vosshenrich
- Determination and isolation of immune populations from brain tumor microenvironments / Javier Godino and Alberto J. Schuhmacher
- Mouse model of colitis-associated colorectal cancer (CAC) : isolation and characterization of mucosal-associated lymphoid cells / Llipsy Santiago, Marta Castro, Julián Pardo, and Maykel Arias
- Cancer exome-based identification of tumor neo-antigens using mass spectrometry / Shelly Kalaora and Yardena Samuels
- Single-cell mass cytometry of archived human epithelial tissue for decoding cancer signaling pathways / Cherie' R. Scurrah, Alan J. Simmons, and Ken S. Lau
- Purification of leukemia-derived exosomes to study microenvironment modulation / Marina Wierz, Sandrine Pierson, Ernesto Gargiulo, Coralie Guerin, Etienne Moussay, and Jerome Paggetti
- Molecular characterization of circulating tumor cells to study cancer immunoevasion / Chiara Nicolazzo, Angela Gradilone, Guido Carpino, Paola Gazzaniga,and Cristina Raimondi
- Quantitative identification of senescent cells in cancer / Anat Biran, Ziv Porat, and Valery Krizhanovsky
- Generation and harnessing of heterotypic tumor-stroma spheroids to study cancer immunosurveillance / Dirk Zboralski and Anna Frömming
- Establishment of slice cultures as a tool to study the cancer immune microenvironment / Xiuyun Jiang, Y. David Seo, Kevin M. Sullivan, and Venu G. Pillarisetty
- Gold standard assessment of immunogenic cell death in oncological mouse models / Juliette Humeau, Sarah Lévesque, Guido Kroemer, and Jonathan G. Pol
- Novel dendritic cell-based vaccination protocol to stimulate immunosurveillance of aggressive cancers / Annunziata Nigro, Barbara Montico, Vincenzo Casolaro, and Jessica Dal Col
- Development of bispecific antibody derivatives for cancer immunotherapy / Yuan He, Wijnand Helfrich, and Edwin Bremer
- Generation of CAR-T cells for cancer immunotherapy / Qumiao Xu, Hizkia Harto, Robert Berahovich, Shirley Xu, Hua Zhou, Vita Golubovskaya, and Lijun Wu.